Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities
Net loss	$ (1,758,182)	$ (1,266,344)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	73,356	62,446
Bad debt expense		5,159
Loss on marketable securities	2,886
Stock-based compensation	60,999	133,656
Derivative income	(107,406)	(309,142)
Amortization of debt discount	394,239	423,682
Interest added to debt - related parties	214,499
Fair value of preferred stock issued for securities	46,363
Notes issued for services	150,000
Common stock issued for financing	21,090
Changes in operating assets and liabilities:
Accounts receivable	(4,442)	(41,574)
Inventory	35,268	53,114
Other current and non-current assets	56,674	(74,203)
Accounts payable and accrued expenses	143,736	100,566
Accrued expenses - related parties	286,506	267,415
Deferred revenues	(31,934)	13,026
Net cash used in operating activities	(416,348)	(632,199)
Cash flows from investing activities
Purchase of property and equipment	(14,250)	(7,778)
Net cash used in investing activities	(14,250)	(7,778)
Cash flows from financing activities
Proceeds from convertible debt	495,000	556,000
Proceeds from line of credit	65,000
Payments on convertible debt	(61,000)	(10,000)
Net cash provided by financing activities	499,000	546,000
Net change in cash and cash equivalents	68,402	(93,977)
Cash and cash equivalents, beginning of period	1,454	95,431
Cash and cash equivalents, end of period	69,856	1,454
Supplemental disclosure of cash flow information:
Income taxes paid
Interest paid	5,655
Supplemental disclosure of noncash investing and financing activities:
Unrealized loss on available for sale investments		28,645
Issuance of common stock for conversion of debt	194,869	430,120
Issuance of common stock for accrued expenses		7,875
Debt discount on convertible notes and warrants	272,146	459,611
Accrued salaries converted into convertible promissory notes		$ 241,050